Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

324 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The use of antidepressants in clinical practice: focus on agomelatine.
McAllister-Williams RH, Baldwin DS, Haddad PM, Bazire S. McAllister-Williams RH, et al. Among authors: baldwin ds. Hum Psychopharmacol. 2010 Mar;25(2):95-102. doi: 10.1002/hup.1094. Hum Psychopharmacol. 2010. PMID: 20196187 Review.
Tolerability of combined treatment with lithium and fluoxetine: 14 cases treated under open conditions.
Hawley CJ, Roberts AG, Baldwin DS. Hawley CJ, et al. Among authors: baldwin ds. Int Clin Psychopharmacol. 1994 Spring;9(1):31-3. doi: 10.1097/00004850-199400910-00005. Int Clin Psychopharmacol. 1994. PMID: 8195580
First clinical experience with olanzapine (LY 170053): results of an open-label safety and dose-ranging study in patients with schizophrenia.
Baldwin DS, Montgomery SA. Baldwin DS, et al. Int Clin Psychopharmacol. 1995 Nov;10(4):239-44. Int Clin Psychopharmacol. 1995. PMID: 8748045 Clinical Trial.
Clinical experience with paroxetine in social anxiety disorder.
Baldwin DS. Baldwin DS. Int Clin Psychopharmacol. 2000 Jul;15 Suppl 1:S19-24. doi: 10.1097/00004850-200007001-00005. Int Clin Psychopharmacol. 2000. PMID: 10994679 Clinical Trial.
A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment.
Baldwin DS, Hawley CJ, Mellors K; CN104-070 Study Group. Baldwin DS, et al. J Psychopharmacol. 2001 Sep;15(3):161-5. doi: 10.1177/026988110101500303. J Psychopharmacol. 2001. PMID: 11565622 Clinical Trial.
Unmet needs in the pharmacological management of depression.
Baldwin DS. Baldwin DS. Hum Psychopharmacol. 2001 Dec;16(S2):S93-S99. doi: 10.1002/hup.337. Hum Psychopharmacol. 2001. PMID: 12404714
Can we distinguish anxiety from depression?
Baldwin DS, Evans DL, Hirschfeld RM, Kasper S. Baldwin DS, et al. Psychopharmacol Bull. 2002 Summer;36 Suppl 2:158-65. Psychopharmacol Bull. 2002. PMID: 12490832 Review.
Quantifying subjective assessment of sleep and life-quality in antidepressant-treated depressed patients.
Mayers AG, van Hooff JC, Baldwin DS. Mayers AG, et al. Among authors: baldwin ds. Hum Psychopharmacol. 2003 Jan;18(1):21-7. doi: 10.1002/hup.438. Hum Psychopharmacol. 2003. PMID: 12532312
Assessing subjective sleep reports in the first-degree relatives of antidepressant-treated depressed outpatients.
Mayers AG, Van Hooff JC, Baldwin DS. Mayers AG, et al. Among authors: baldwin ds. Hum Psychopharmacol. 2003 Apr;18(3):207-14. doi: 10.1002/hup.475. Hum Psychopharmacol. 2003. PMID: 12672173
Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder.
Mogg K, Baldwin DS, Brodrick P, Bradley BP. Mogg K, et al. Among authors: baldwin ds. Psychopharmacology (Berl). 2004 Nov;176(3-4):466-70. doi: 10.1007/s00213-004-1902-y. Epub 2004 May 7. Psychopharmacology (Berl). 2004. PMID: 15549278 Clinical Trial.
324 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback